Humacyte, Inc. (HUMA) Social Stream



Humacyte, Inc. (HUMA): $3.11

0.01 (+0.32%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add HUMA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#332 of 363

in industry

HUMACYTE INC (HUMA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering HUMACYTE INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 5 $20 $16 $17.8 $2.7 559.26%
2022-01-31 6 $20 $16 $17.8 $2.7 559.26%
2022-02-01 6 $20 $12 $16.8 $2.7 522.22%
2022-03-31 6 $20 $10 $15.833 $2.7 486.41%
2022-05-16 5 $19 $4 $13.8 $2.7 411.11%
2022-05-17 5 $19 $4 $13 $2.7 381.48%
2022-08-15 5 $18 $3.5 $9.5 $2.7 251.85%
2022-11-15 5 $18 $2.75 $8.75 $2.7 224.07%
2022-12-19 4 $18 $2.75 $8.15 $2.7 201.85%
2023-03-24 5 $18 $2.75 $8.15 $2.7 201.85%
2023-05-15 5 $16 $2.75 $7.75 $2.7 187.04%
2023-06-22 6 $16 $2.75 $6.95 $2.7 157.41%
2023-08-15 5 $16 $3.5 $7.1 $2.7 162.96%
2023-09-13 6 $16 $3.5 $7.3 $2.7 170.37%
2023-11-10 6 $16 $3 $7.2 $2.7 166.67%
2023-12-11 7 $16 $3 $7 $2.7 159.26%

The Trend in the Analyst Price Target


Over the past 13 months, HUMA's average price target has gone down $1.75.

Over the past 37 weeks, HUMA's average upside potential has been 136.25%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-28 5 16 2.75 7.750 3.18 143.71%
2023-06-22 6 16 2.75 6.950 2.93 137.2%
2023-06-22 5 16 2.75 6.950 2.93 137.2%
2023-06-22 6 16 2.75 7.458 2.93 154.54%
2023-08-15 5 16 3.50 7.100 4.48 58.48%

HUMA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.29 6 0 1 0 0 7

The Trend in the Broker Recommendations


HUMA's average broker recommendation rating improved by 0.51 over the prior 26 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • HUMA has a lower variance in analysts' estimates than -1936.01% of all US stocks.
  • In the context of all US stocks, HUMACYTE INC's upside potential (average analyst target price relative to current price) is higher than 2140.96% of them.
  • In terms of how HUMACYTE INC fares relative to all US stocks, note that its average analyst price target is higher than 285.95% of that group.
  • In the context of Healthcare stocks, HUMACYTE INC's number of analysts covering the stock is higher than 687.56% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HUMACYTE INC are TSHA, OPT, and TARS.

Make investment decisions regarding HUMA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!